Delivery Order SPE2DB22D3501-SPE2DB24FVV14

Award Date 5/30/24
Potential Completion Date 5/31/24
Potential Value $6.6K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The $1,412.04 Firm Fixed Price Delivery Order is for the supply of 4564882116 - ATOVAQUONE-PROGUANIL 250-100 100S, a pharmaceutical product. The contract does not have a set-aside designation. Amerisourcebergen, a major pharmaceutical distribution company, holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical worth up to...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $1,179.16 firm fixed-price delivery order is for the procurement of 4567038515 ! ATOVAQUONE-PROGUANIL 250-100 100S, a pharmaceutical product. The award does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award, valued at $1,032.53, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the delivery of the pharmaceutical product Atovaquone-Proguanil 250-100 UD 24S. Amerisourcebergen, a major pharmaceutical distribution company, holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025, to provide a comprehensive range of...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,834.97 Firm Fixed Price Delivery Order is for the supply of 4560733457 ! ATOVAQUONE-PROGUANIL 250-100 100S medical products. This award is part of Amerisourcebergen's larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a comprehensive...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The award, valued at $21,722.79, is a firm fixed price delivery order for ATOVAQUONE-PROGUANIL 250-100 100S, a specialty pharmaceutical product. The award has no set-aside designation and is part of a larger indefinite delivery contract (IDC)...
This federal contract award, valued at $9,567.00, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corporation's Corporate Office Division. The contract is for the delivery of ATOVAQUONE-PROGUANIL 250-100 UD 24S, a pharmaceutical product, to support military treatment facilities and healthcare programs. The contract has a completion date of September 20, 2024 and is a firm fixed-price delivery order. Amerisourcebergen, a major pharmaceutical...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $12,462.21 firm fixed-price delivery order is for the supply of ATOVAQUONE-PROGUANIL 250-100 100S, a pharmaceutical product. The contract has an ultimate completion date of January 27, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,900.43 firm fixed-price delivery order is for the supply of ATOVAQUONE-PROGUANIL 250-100 100S, a medical product classified under the 4566811967 government description code. The award does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant $999,999,999...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,316.71, is for the delivery of 4562406756 ATOVAQUONE-PROGUANIL 250-100 UD 24S, a medical supply. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of October 6, 2023. No set-aside designation was used for this award. Amerisourcebergen holds...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a Delivery Order valued at $6,719.00 under a larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the supply of ATOVAQUONE-PROGUANIL 250-100 100S, a pharmaceutical product, to support military healthcare programs. The IDC, valued at $999,999,999, serves as a primary vehicle for providing a comprehensive range of...
  • SPE2DB22D3501
    Indefinite Delivery Contract
  • SPE2DB22D3501-SPE2DB24FVV14
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The $6,581.98 firm fixed-price delivery order is for the supply of ATOVAQUONE-PROGUANIL 250-100 100S pharmaceutical products. The contract has no set-aside designation.

Amerisourcebergen is a major pharmaceutical distribution company that holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. The company also holds a smaller $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs.

Generated 8/29/24, 9:44 AM